Kos Biotechnology Partners and FORTH Announce Strategic Partnership to Advance Biotechnology Innovation in Greece
The incubator will give startups access to FORTH labs, equipment and research expertise as Kos and FORTH aim to build a global biotech hub.
7 Articles
7 Articles
Kos Biotechnology Partners and FORTH Announce Strategic Partnership to Advance Biotechnology Innovation in Greece
NEW YORK and ATHENS, Greece and HERAKLION, Greece, Nov. 16, 2026 /PRNewswire/ -- Kos Biotechnology Partners ("Kos") and the Foundation for Research and Technology-Hellas ("FORTH") have entered into a Memorandum of Understanding (MOU) to develop, support, and house a world-class…
From the five investments it has already made, Kos Biotechnology Partners, the first fund focused on biotechnology, wants to reach nine by the end of 2026...More...
With capital of 111 million euros and five investments already in its portfolio, the fund supported by EATE seeks to bring international life sciences companies, research activities and specialized jobs to Greece.
With capital of 111 million euros, the fund invests in biotechnology, drug discovery and specialized pharmaceutical services companies.
With four new investments by the end of 2026 and a plan for a research hub in Crete, KOS Biotechnology aims to attract international companies to Greece.
KOS Biotechnology Partners directs capital to companies seeking new drugs for cancer, neurological and rare diseases, linking its investments with the creation of a research and business presence in Greece and proceeding with the establishment of a biotechnology hub in Crete. With capital of 111 million euros and a target of approximately 20 investments, the fund is preparing […] The article KOS Biotechnology Partners: The 111 million euro fund …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium










